Sponsor:
Mayo Clinic
Code:
NCT07291011
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
Electronic Health Record Review
Mindfulness Relaxation
Questionnaire Administration
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT07291011
Start date
Nov 5, 2025
Status verified date
Jun, 2026
Completion date
Nov 15, 2029
Anticipated
Primary completion date
Nov 15, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
45 participants
Anticipated
Intervention Model
Single group
Primary purpose
Supportive Care
Arms
experimental: Supportive care (MBSR)
Interventions
Electronic Health Record Review
Mindfulness Relaxation
Questionnaire Administration
Primary outcome measure
Central contacts
Ahauve Orusa, MD, MPH
507-284-5162Locations
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Ahauve Oruse, MD, MPH
507-284-5162Principal Investigator:
Stacy D. D'Andre
Sponsor
Mayo Clinic
Last update posted
Jun 23, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-06-23.